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Abstract 
Background: Adaptive evolution is not possible without the generation of phenotypic variants. The origin of these 
variations has been a central topic in evolutionary biology. Up to now, it was commonly accepted that standing 
genetic variation is the only cause of phenotypic variants. However, epigenetic information is emerging as a comple‑
mentary source of heritable phenotypic variation that contributes to evolution. The relative importance of genetics 
and epigenetics in generating heritable phenotypic variation is nevertheless a matter of debate.
Results: We used a host–parasite system to address this question. The human blood fluke Schistosoma mansoni 
can adapt rapidly to new intermediate snail hosts. The interaction between parasite and mollusk is characterized by 
a compatibility polymorphism illustrating the evolutionary dynamics in this system. The principal molecular marker 
for compatibility (infection success) is the expression pattern of a group of polymorphic mucins (SmPoMuc) in the 
parasite. We show here that chromatin structure changes as the SmPoMuc promoters are the cause for SmPoMuc 
transcription polymorphism leading to phenotypic novelty and increase in infection success, i.e., fitness.
Conclusion: We establish that epigenetic changes can be the major if not only cause of adaptive phenotypic vari‑
ants in Schistosoma mansoni, suggesting that epimutations can provide material for adaptive evolution in the absence 
of genetic variation in other systems. In addition, our results indicate that epidrugs can be used to control parasite 
development but also parasite evolution.
Keywords: Epigenetics, Adaptive evolution, Compatibility polymorphism, Schistosoma mansoni
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Adaptive evolution relies on the generation of heritable 
phenotypic variants on which selection can act. The ori-
gin of variation has puzzled researchers since Darwin-
ian times [1]. There is now a relative broad consensus 
that genotype environment interactions represent the 
major, if not exclusive, source of phenotypic novelty. 
However, this view has been challenged by theoretical 
considerations [2–5], and it has been suggested that a 
substantial part of variability is the result of variations in 
the epigenetic component of the genome [6, 7]. A con-
cept emerges in which upon environmental changes, the 
epigenetic (“low-fidelity”) system permits a population to 
generate new phenotypes while keeping genetic informa-
tion invariant. This allows for exploring the fitness land-
scape after an environmental change and will “buy time” 
for this population. If the new environment persists, 
genetically encoded phenotypic variants could emerge 
and the new phenotype could be genetically assimilated. 
Heritability of epialleles has been clearly established for 
numerous examples (e.g., [8, 9]), and several epigeneti-
cally encoded phenotypic characters were described (e.g., 
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[10, 11]). However, none of them is adaptive in the sense 
that the phenotype provides a fitness gain and is favored 
by selection under ecologically realistic conditions. It 
remains therefore an open question whether epigenetic 
inheritance contributes significantly to adaptive evolu-
tion. We addressed this question choosing a metazoan 
host/parasite system. Selective pressures are strong in 
these systems, evolution is fast and effective popula-
tion sizes are small. We provide here, to the best of our 
knowledge, for the first time experimental evidence for 
an epigenetically encoded adaptive phenotype.
The parasite/host system we used is the interaction 
between Schistosoma mansoni and its intermediate 
host Biomphalaria glabrata. S. mansoni is a parasite of 
humans and causes intestinal schistosomiasis, the second 
most important human parasitic disease after malaria 
[12]. The life cycle requires passage through two obliga-
tory hosts, the freshwater snail Biomphalaria spp. where 
the parasite multiplies asexually, and human or rodents 
as definitive hosts for sexual reproduction [13]. The snail/
schistosome interaction is characterized by a phenome-
non called compatibility polymorphism [14], i.e., specific 
strains of S. mansoni can only infect specific strains of 
B. glabrata, while others cannot be infected [15]. These 
incompatible snail strains are, however, not resistant to 
S. mansoni since they can be infected by other strains of 
the parasite. We had earlier identified S. mansoni poly-
morphic mucins (SmPoMucs) as key molecular mark-
ers for compatibility [16, 17]. For several reasons, these 
proteins appear to be essential for the parasites to pen-
etrate into the snail: (1) SmPoMucs are expressed only 
in the snail infecting miracidia where they are excreted 
from the apical gland of the larvae. (2) SmPoMucs pre-
sent the strongest qualitative and quantitative differences 
between compatible and incompatible strains on the level 
of the proteome. Their exact function remains unknown 
but their amino acid sequence and glycosylation level 
[18] suggests that and (3) they form mucus that facilitates 
penetration through the snail epidermis. (4) They are rec-
ognized by the immune receptors of the invertebrate host 
[19] which triggers probably elimination of sporocysts of 
incompatible S. mansoni strains. SmPoMucs are encoded 
by a multigene family that comprises at least 10 genes, 
organized in four clusters on the genome. These genes 
belong to a class of genes that are probably specific to 
Platyhelminthes and are called micro-exon genes (MEGs) 
[20]. The unusual structure of MEGs allows parasites to 
generate a “controlled chaos” of a polymorphic SmPoMuc 
protein repertoire from a small number of genes using 
transcriptional, post-transcriptional and post-transla-
tional mechanisms [17]. We recently demonstrated that 
transcriptional control is based on epigenetic mecha-
nisms [21]. We reasoned therefore that the compatibility 
phenotype would be a suitable model to disentangle the 
effects of genetically and epigenetically heritable compo-
nents on adaptive traits. We applied a classical pedigree 
study and used two pure lines of S. mansoni: the Brazil-
ian SmBRE strain and the Guadeloupian SmGH2 strain 
with their sympatric Brazilian snail strain BgBRE and the 
Guadeloupian strain BgGUA, respectively. Both strains 
show strong differences in compatibility (measured by 
prevalence and intensities) toward the same reference B. 
glabrata strain [15]. As mentioned above, SmPoMucs are 
the key elements in the compatibility polymorphism [16], 
and expression of this gene family is regulated by epige-
netic mechanisms [21, 22]. We therefore investigated 
expression of these genes and studied chromatin struc-
ture and DNA sequence in the promoter regions. We 
show that the compatibility phenotype and SmPoMuc 
expression follow non-Mendelian segregation, that epi-
alleles and alleles of SmPoMuc do not cosegregate, and 
that treatment with an epimutagen modifies SmPoMuc 
expression and increases fitness of the treated parasite 
larvae. Taken together our results indicate that not only 
SmPoMuc expression but also infection success are at 
least partially under epigenetic control, thus providing an 
example for an epigenetically encoded adaptive trait.
Results
Inbred S. mansoni strains used in the study are pure lines
Our laboratory maintains the life cycle of currently five 
inbred strains of Schistosoma mansoni and their cor-
responding sympatric Biomphalaria glabrata host 
strains. These strains show a specific heritable reac-
tion norm in their compatibility with B. glabrata strains 
[15]. Every strain possesses also a specific heritable pat-
tern of SmPoMuc so that we can “fingerprint” them by 
Western blots. To investigate whether the capacity to 
infect allopatric hosts can be selected for, we performed 
infections in allopatric combinations SmBRE/BgGUA 
and SmBRE/BgVEN and measured compatibility. The 
SmBRE strain was originally sampled in Recife, Brazil, 
in the 1960s. It was provided to our laboratory in 1975 
by Pr. Y. Golvan (Faculté de Médecine de Paris—Saint 
Antoine) and since then has been maintained in its sym-
patric intermediate host strain BgBRE. BgBRE is also 
from Recife and was also acquired in 1975. The allopatric 
mollusk strain BgGUA originates from the town of Dans 
Fond and arrived at our laboratory in 2005. Snail strains 
BgVEN were originally sampled in Venezuela. Preva-
lence (percentage of infected snails) is roughly 80 % in the 
allopatric combinations (SmBRE on BgGUA or BgVEN) 
compared to the sympatric combination (SmBRE on 
BgBRE) where it is 100  % and this without significant 
variations for the six generations (Fig.  1a, b). What-
ever the generation, offspring of both Schistosoma lines 
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passed through allopatric snail hosts showed the same 
compatibility phenotype toward the original sympatric 
BgBRE snail strain (100 %, Fig. 1a, b). Similar results were 
obtained for another S. mansoni strain, SmGH2, hence 
fewer generations were followed. SmGH2 was collected 
in 1983 from eggs shed by a patient in the hospital of 
Pointe-à-Pitre. Since then it was maintained in the labo-
ratory in its sympatric snail host BgGUA. About 60 % of 
snails are infected in the sympatric (SmGH2 on BgGUA) 
combination and less than 5  % in the allopatric combi-
nation (SmGH2 on BgBRE). Neither a gain of compat-
ibility with the allopatric host nor a loss of compatibility 
with the sympatric host was detected. This means that 
the compatibility character cannot be selected for, i.e., 
offspring from allopatric combinations shows the same 
reaction norm as the original population. Therefore, even 
though the used strains are not clonal [23], they are pure 
lines in the sense of classical genetics.
SmPoMucs are involved in an early stage of host/parasite 
interaction
In order to infect its host, a parasite must find the host, 
adhere to the surface, penetrate and finally evade immune 
response inside the host. SmPoMucs could be involved 
in any of these processes, but their constitutive expres-
sion in the apical glands of miracidia suggested involve-
ment in the early steps, i.e., adherence and penetration. 
We reasoned that if this would be true, then bypassing 
penetration by transfer of sporocysts into snails would 
lead to no difference in prevalence between allopatric 
and sympatric combinations. Our results show that there 
is indeed no difference in the development of S. man-
soni after transfer into the allopatric (SmBRE in BgGUA) 
vs the sympatric combination (SmBRE in BgBRE). In 
other words, if SmBRE arrives inside the BgGUA snail it 
behaves there as in a sympatric host (Additional file  1). 
This shows that when infecting allopatric BgGUA snails, 
the limiting step is penetration and not sporocyst SpI 
development, and lends further support to the hypoth-
esis that SmPoMucs are involved in penetration or very 
early transformation steps.
Strain hybrids express more SmPoMuc variants than each 
parent
We decided to introduce diversity by generating crosses 
between SmBRE and SmGH2. Thirty five to fifty snails 
from each strain (BgBRE and BgGUA) were exposed indi-
vidually to 20 miracidia. Prevalence and intensity (num-
ber of mother sporocysts spI per snail) were measured. 
At each step, miracidia were set aside to perform molec-
ular biology analyses. The experiments were carried out 
with miracidia obtained from SmBRE  ×  SmBRE and 
SmGH2 ×  SmGH2 crosses, F1 miracidia obtained from 
reciprocal crosses of SmBRE  ×  SmGH2, F2 miracidia 
were obtained from F1 × F1 and F3 miracidia obtained 
from crosses of two different clonal populations of F2 cer-
cariae. The experimental scheme is summarized in Fig. 2. 
Quantitative RT-PCR shows that SmPoMuc 3.1(r1r2) 
is on average 18.3-fold more transcribed in SmGH2 F0 
than in SmBRE F0 strains (n  =  4), and ChIP indicates 
a 12.05-fold higher acetylation of H3K9 in SmGH2 F0 
compared to SmBRE F0 (n  =  7) (Fig.  3). This confirms 
our earlier results that major control of expression of 
these genes occurs at the transcriptional level [21]. The 
hybrid lines F1 and F2 show higher transcription levels 
compared to SmBRE F0 parent (data not shown). In the 
F3 generation, SmPoMuc 3.1(r1r2) transcription is statis-
tically not anymore different from SmBRE F0 (Fig. 3). We 
wondered if such differences in transcription levels con-
cerned also other genes and tested 14 arbitrarily chosen 
Fig. 1 Compatibility of the SmBRE schistosome strain with its homopatric snail host BgBRE and two heteropatric snail strains, BgGUA and BgVEN:  
a SmBREg corresponds to the SmBRE strain passed for 6 generations (G1–G6) on BgGUA snails; b SmBREv corresponds to the SmBRE strain passed 
for 6 generations (G1–G6) on the BgVEN snails. At each generation, compatibility of the SmBREg (a) and SmBREv (b) was tested on the original 
BgBRE snail strain
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protein coding genes and transcribed repeats by qRT-
PCR (genes and primers in Additional file 4). In none of 
the cases, we detected significant differences in transcrip-
tion between the 4 generations (data not shown). We 
then used Western blots to test if SmPoMuc transcripts 
are translated. SmPoMucs proteins were detected using 
an antibody that recognizes the C-terminal conserved 
sequence by Western blot [19]. Proteins were extracted 
Fig. 2 Crossing scheme for pedigree study. After monomiracidial infection of their sympatric hosts in F0, crosses within each generation were 
produced in each generation until F3
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from 1000 miracidia for each condition. We knew already 
that although there is very little nucleotide differences in 
the promoter regions of SmPoMucs family genes [21], the 
expression profiles between the parental strains SmBRE 
F0 and SmGH2 F0 were different [19], and we confirmed 
this here by Western blot (Fig.  4a). F1 hybrid miracidia 
express all bands of F0 parents, leading to a combined 
profile that corresponds almost perfectly to a superpo-
sition of SmGH2 and SmBRE parental profiles (Fig.  4a). 
In F2 and F3, we still find all bands of F0 parents even 
if their proportions change (Fig. 4b). Western blots were 
repeated with three F3 clones, and regardless of their 
genotype we always found the combined pattern of 
SmPoMuc expression. Since SmPoMucs are key markers 
for host–parasite compatibility, we expected the hybrids 
with a combined SmPoMuc profile to show changes in 
compatibility. We therefore investigated their capacity to 
infest different snail strains.
F3 Hybrids show higher fitness than the parents
Prevalences in BgBRE are 96–100  % for SmBRE F0 and 
4–6 % for SmGH2 F0. Prevalences increase significantly 
(Fisher exact test, p  <  0.0001) compared to SmGH2 
in F1, F2 and F3 to reach maximal values in F2 and F3 
(Fig.  5***). Prevalences are statistically not different 
from SmBRE F0 in all hybrid generations, thus we con-
sider them to be similar. Intensity in BgBRE is 7.1 ± 0.25 
(mean ± SE) for SmBRE (n = 34) and 1 ± 0 for SmGH2 
(n = 50). Similar to prevalence, intensity values increase 
significantly compared to SmGH2 in F1, F2 and F3 
(Fig. 5).
In BgGUA snails, prevalences are 80–83 and 55–60 % 
for parental miracidia SmBRE F0 and SmGH2 F0, respec-
tively. F1–F3 have infectivities that are statistically not 
different from SmBRE F0 (p  <  0.05, Fisher exact test) 
but higher than those of the SmGH2 F0 parents (Fig. 5). 
For infection intensities of F0–F3 on BgGUA, there is 
no significant difference between SmBRE and SmGH2 
F0 parents, but we observe an increase in intensity val-
ues across generations F1–F3 (Fig. 5). The measure of the 
superior performance, i.e., heterosis on intensity param-
eter was calculated following the formula ((Crossbred 
average  −  Parental average)/Parental average)  ×  100. 
On BgBRE, the crossbred F1 intensity is roughly 40  % 
greater than the average parental intensity. Consequently, 
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Fig. 3 Boxplot of chromatin structure and transcription level in the promoter region of SmPoMuc3.1 (r1r2). Two technical replicates for each biologi‑
cal replicate (n). a ChIP H3K9me3 to H3K9ac ratio at the promoter of SmPoMuc 3.1(r1r2). b Relative transcription of SmPoMuc 3.1(r1r2) compared 
to alpha‑tubulin measured by RT‑qPCR. ***indicate statistical significant differences according to ANOVA followed by Dunnett’s post hoc test to F0 
SmBRE that was defined as reference (ANOVA F2,8 = 13.128; p = 0.003 for transcription and F2,14=7.26; p = 0.007 for H3K9me3/ac ChIP ratio). Only 
SmGH2 is significantly different in chromatin structure and transcription level from the reference. Genotype SmGH2 of the F3 is similar (not differ‑
ent) to reference genotype F0 SmBre in terms of chromatin structure and transcription. For additional pairwise comparison we used Students T‑Test. 
We found for H3K9me3/ac ratio (a) t = 10.045, 8 df, p < 0.0001, i.e. there is statistically significant difference between SmGH2 and F3‑SmGH2. For 
transcription (b) the difference between SmGH2 and F3‑SmGH2 is statistically not significant (t = 1.514; 5 df; p = 0.1904) since variance is strong. 
Nevertheless, there is a clear shift of transcription in F3‑SmGH2 towards the lower level of transcription observed in SmBRE
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mansoni show increasing infection success of hybrids 
over three generations, i.e., an increase in global fitness. 
Interestingly, while the SmPoMuc expression (molecular) 
phenotype is additive, compatibility phenotypes in F2 and 
F3 hybrids show uniparental phenotypic dominance of 
SmBRE. Segregation of SmPoMuc patterns and infection 
success is uncoupled, which is inconsistent with Men-
delian genetic inheritance of a single locus or few loci. 
Consequently, we explored other mechanisms responsi-
ble for fitness increase. Since we had earlier shown that 
chromatin structure controls SmPoMuc expression [21], 
we decided to study segregation of chromatin marks at 
the SmPoMuc locus that shows the strongest chromatin 
structure differences and expression differences between 
SmBRE and SmGH2: SmPoMuc 3.1 (r1r2).
Chromatin structure in SmPoMuc 3.1(r1r2) shows 
non‑Mendelian segregation
SmPoMuc promoter sequences do not have methylated 
cytosines [21]. Therefore, we focused our analysis on 
histone modifications in the promoter regions by native 
chromatin immunoprecipitation (N-ChIP) using two dif-
ferent antibodies that recognize histone H3 acetylated 
on lysine 9 (H3K9ac) and histone H3 tri-methylated on 
lysine 9 (H3K9me3). ChIP was followed by qPCR analysis 
to quantify the immunoprecipitated DNA. Since acety-
lation and methylation at H3K9 are mutually exclusive, 
we express chromatin status here as ratio of H3K9me3/
H3K9ac. SmPoMuc 3.1(r1r2) promoter shows a very dif-
ferent chromatin structure between the two F0 parents 
SmBRE and SmGH2 (Fig. 3). This is correlated with dif-
ferential expression of this gene between the two par-
ents. In F3, chromatin structure is closer to the SmBRE 
F0 parent (Fig. 3). The promoter regions of SmPoMuc 3.1 
(r1r2) contain 3 diagnostic SNPs between SmBRE F0 and 
SmGH2 F0. To identify the genotypes at SmPoMuc 3.1 
(r1r2), we PCR-amplified and sequenced the SmPoMuc 
3.1 (r1r2) region using DNA of miracidia from all genera-
tions SmBRE F0, SmGH2 F0, F1, F2 and F3. As expected, 
F1 and F2 hybrid populations are heterozygous with 



















































Fig. 4 Expression profiles of SmPoMucs. Western blot experiments were performed using a standardized method on proteins extracts from 1000 
miracidia. Image was analyzed and grayscale (intensity on y axis) indicates protein abundance. X‑axis migration distance in inches. a SmPoMucs 
expression in F0 (full and dashed lines) and F1 (dotted line). F1 profile corresponds almost perfectly to the combination of both F0. b Comparison of 
SmPoMucs expression in F1, F2 and F3. Global profile remains constant but 3 major bands decrease in intensity. c SmPoMucs expression in SmLE 
with (dot-and-dash line) and without TSA (full line) treatment. After TSA treatment, latent variants are now expressed (indicated by arrowheads)
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two different parental alleles. We then studied in more 
detail F3 clones homozygous for the SmGH2 genotype. 
We found that the SmPoMuc 3.1 (r1r2) SmGH2 geno-
type had aquired in F3 an epigenotype that is statistically 
not different from SmBRE F0. One might argue that this 
is part of a genome-wide change in chromatin structure 
following the hybridization event. We therefore investi-
gated another locus for which we had earlier identified 
differences in H3K9ac enrichment between SmBRE and 
SmGH2 [24]: Smp_171100.
Smp_171100 codes for a putative M13 metallo-endo-
peptidases and is located on Schisto_mansoni.Chr_2 
22,414,795–22,470,759. The function of the gene is not 
of particular importance here. The gene is not anymore 
listed in the latest version of the genome annotation, but 
we have confirmed the presence of a transcript by RT-
PCR. We had shown earlier that chromatin differences 
exist in the gene body between SmBRE and SmGH2 [24], 
and we used them here as epigenetic markers for both 
strains. We confirmed our findings that SmBRE F0 and 
SmGH2 F0 show different H3K9me3/H3K9ac ratios. 
These differences in chromatin structure are correlated 
with transcription differences (Fig. 6). It should be noted 
that the difference is located in the body of the gene 
and not in the TSS, which explains the inverse relation 
of acetylation and expression. In the F3, the H3K9me3/
H3K9ac ratio is not different from SmBRE F0 (Fig. 6). We 
sequenced a region of the Smp_171100 gene sequence 
containing 6 SNPs between SmBRE and SmGH2. As 
expected and as in SmPoMuc 3.1 (r1r2), F1 and F2 
miracidial populations are heterozygous. The F3 clone 
that has the SmGH2 alleles for SmPoMuc 3.1 (r1r2)) is 
homozygous for SmBRE in Smp_171100.
In conclusion, while in the SmPoMuc 3.1(r1r2) locus, 
the SmGH2 genotype had changed the epigenotype in 
the F3 (Fig.  3), in Smp_171100 we see a co-segregation 
of epigenotype and genotype (both are SmBRE in F3). In 
other words, for the two loci in which to our knowledge 
there is a clear epigenetic difference between SmBRE F0 
and SmGH2 F0, we distinguish two modes of chroma-
tin heritability, one case of non-Mendelian inheritance 
(SmPoMuc 3.1(r1r2)), and one case of Mendelian inher-
itance and cosegregation of genotype and epigenotype 
(Smp_171100).
Pharmacological induction of chromatin structure 
changes leads to transcription of new SmPoMuc variants 
and renders incompatible (avirulent) strain compatible 
(virulent)
All lines of evidence indicated that it was the H3K9me3/
ac ratio that controlled specifically SmPoMuc 3.1(r1r2) 
expression and that the change in chromatin structure 
resulted in new phenotypic variants based on new com-
binations of SmPoMuc. This in turn led probably to the 
increase in infection success of the hybrids. If this was 




Fig. 5 Prevalence and intensity of S. mansoni infection in B. glabrata snail strains. Prevalence is expressed as % of infected snails, intensity as mean 
number of SpI sporocysts per snail. ***indicate were prevalences and intensities increase significantly (Fisher’s exact test, p < 0.0001) compared to 
SmGH2. They are not different from SmBRE F0 (p < 0.05). Each individual snail was exposed to 20 miracidia
Page 8 of 13Fneich et al. Epigenetics & Chromatin  (2016) 9:27 
means should also lead to new SmPoMuc variants and 
should have an impact on parasite–host compatibility. 
Locus-specific epigenetic engineering of SmPoMuc is 
not yet feasible. We therefore opted for pharmacological 
treatment of S. mansoni eggs with the histone deacetylase 
inhibitor Trichostatin A (TSA). We had shown earlier that 
treatment with 20 µM TSA increased the number of alter-
native transcripts (number of polymorphic bands detected 
by RT-PCR) in SmPoMuc but did not alter transcription of 
the abovementioned control genes [22]. Also in other sys-
tems, it was shown that TSA modulates transcription of 
around 5  % of genes and that genes can be up-regulated 
but also down-regulated by TSA [25–28]. In other words, 
TSA does not induce a global increase in transcription but 
will activate or inactivate certain loci only. We treated the 
S. mansoni eggs three times with 20 µM TSA before hatch-
ing. This dose have negligible cytotoxic effect [22]. For this 
part of the study, we used again two pure lines of S. man-
soni: the Brazilian SmLE strain (originally from Belo Hori-
zonte) and SmGH2 strain with the Brazilian snail BgBAR2 
(sympatric with SmLE and also coming initially from Belo 
Horizonte). The SmLE/SmGH2—BgBAR combinations 
were chosen because they have a very pronounced phe-
notype both in terms of compatibility (SmGH2 has almost 
no capacity to infect of BgBAR, but SmLE is highly com-
patible) and in SmPoMuc expression (only 2 strong bands 
in Western blots in SmLE). Analysis of Western blots 
shows that TSA treatment leads to increased expression 
of SmPoMuc protein variants in the miracidia that were 
latent in the untreated control (arrowheads in Fig. 4c), i.e., 
the already known transcription variation translates also 
into changes of the protein level. We subsequently inves-
tigated the compatibility phenotype using prevalences and 
intensities with mock treatment and with TSA treatment. 
BgBAR snails were exposed individually to 20 miracidia. 
Using only the solvent ethanol as treatment, mean preva-
lences in BgBAR are 95.65  % (number of exposed snails 
n = 23) for SmLE, and 21.5 % for SmGH2 (n = 97). Mean 
prevalences increased after treatment with TSA by 4–9 %: 
with TSA they reach 31.1  % (n =  103) for SmGH2, and 
100 % in SmLE (n = 22). This is, however, not yet signifi-
cant (Fisher exact test, p < 0.05). For intensity values, we 
detected an increase for SmGH2 from 2.9 to 4.0 after TSA 
treatment, and for SmLE from 2 to 9.55. This increase in 
individual infection success is significant (Fisher exact test, 
p < 0.05). Experiments were repeated four times by differ-
ent experimenters (raw data provided as Additional file 2).
In conclusion, treatment with an epimutagenic agent 
does not only lead to changes in the SmPoMuc expres-
sion patterns but also allows a parasite with low compat-
ibility to increase its compatibility with a new snail host.
Discussion
In parasite–host interactions, infection success can be 
used as an estimation for parasite fitness. It can be meas-




















































Fig. 6 Boxplot of transcription level and chromatin structure in the gene body of Smp_171100. Two technical replicates for each biological replicate 
(n). a ChIP H3K9me3 to H3K9ac ratio. b Relative transcription compared to alpha‑tubulin measured by RT‑qPCR. ***indicate statistically significant 
differences as in Fig. 3 (ANOVA F2,8 = 7.56; p = 0.014 for transcription and F2,8 = 7.020; p = 0.017 for H3K9me3/ac ChIP ratio). Transcription level and 
chromatin structure co‑segregate with the genotype
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and number of successful infection events per host indi-
vidual (intensity). Using these parameters, we show here 
that after a hybridization event between two different S. 
mansoni strains, the offspring shows increased fitness. 
Increased fitness of hybrids is not surprising [29, 30], but 
in general such hybrid vigor or heterosis is attributed to 
increased genetic diversity in the offspring. This is prob-
ably also the case in S. mansoni, and host compatibility 
has necessarily a genetic basis. However, here we demon-
strate that genetic diversity is not the only mechanism by 
which phenotypic diversity increases in hybrids. At least 
for the SmPoMuc loci, epigenetic plays a more important 
role. This makes sense in light of the fact that nucleotide 
diversity between the two parental strains at these loci 
is extremely low [21]. One of the caveats of our study is 
that we did not address the question by which mecha-
nism chromatin structure is modified. It could be that 
the SmBRE locus is paramutagenic for SmGH2. Paramu-
tation is a heritable change in the expression of a para-
mutable allele, initiated by interaction in heterozygotes 
with a paramutagenic allele. Paramutations are meioti-
cally stable and inherited in the absence of the inducing 
allele (e.g., [10]). Recent work places DNMT2, an enzyme 
that is able to methylate cytosine residues in tRNA, in the 
center of the paramutation pathway in animals [31] and a 
DNMT2 homologue (Smp_198180) exists in S. mansoni 
[32]. Another limitation in our approach comes from the 
non-specificity of the pharmacological induction of epi-
mutations. We observed new SmPoMuc combinations 
without changing the genetic background, and we tested 
a large number of reference genes that did not change 
transcription after TSA treatment, but we cannot exclude 
that transcription in other loci is modified. Nevertheless, 
we confirmed our earlier findings that epigenetic mecha-
nisms control transcription of the SmPoMuc genes and 
we show now that epigenetic information is indeed the 
origin of phenotypic novelty in these loci. The exact func-
tion of SmPoMucs is still elusive; nevertheless, our ear-
lier studies had firmly established SmPoMuc variability as 
a key marker for compatibility between S. mansoni and 
its intermediate host [17, 19], and here, we show that 
SmPoMucs are involved in the very early steps of infec-
tion (adherence, penetration and/or pre-Sp1 develop-
ment). We conclude that strain hybridization and TSA 
treatment lead to changes in the epigenetic information 
that establish novel developmental trajectories leading 
to new and more phenotypic variants in the population. 
This allows the parasite population to explore the fit-
ness landscape. If new matching phenotypes between 
parasites and mollusk host are produced, the latter can 
be infected, i.e., the phenotype is adaptive. This strat-
egy might have evolved as a result of the combination 
of characteristics of the two hosts. Snail populations in 
endemic areas show very low prevalence (e.g., [33]), and 
it is often impossible to catch infected snail. This high 
selective pressure has led to local adaptation and compat-
ibility with allopatric snail strains. Sexual reproduction 
of the parasite takes place within the vertebrate host, and 
when miraciadia are released they must immediately find 
a suitable snail host: at 25  °C, infection success declines 
rapidly 4 h after hatching and is zero after 12 h [34]. Non-
migrating human hosts (e.g, school children) will shed 
eggs good for infection of sympatric snails. However, 
vertebrate hosts might also disperse (e.g., herdsmen) 
and parasite offspring might encounter allopatric snail 
hosts in this case. If the parasite cannot sense migra-
tion, a mixed stable/bet-hatching strategy would be best. 
However, if the parasite could sense migration of the host 
through dietary changes (e.g., different food, beverages, 
and starvation), modification of biorhythm (e.g., migra-
tion at night) or hormonal changes (e.g., stress), a switch 
from stable transmission to bet-hatching would be even 
more successful. The need of the parasite to receive trig-
gers from the vertebrate host to complete its maturation 
is well documented and several hormones have been 
identified that alter parasite development (reviewed in 
[35]). In this sense, our TSA treatment might have mim-
icked events that trigger the switch between low and 
high phenotypic diversity. A schematic representation of 
this scenario is given in Additional file  3. Further work 
is needed to identify the biological trigger that leads to 
increased phenotypic variation in S. mansoni miracidia. 
Nevertheless, our findings fit already perfectly into 
theoretical models that predict such a function for the 
epigenetic information [2, 4] and are to the best of our 
knowledge the first experimental evidence for an epige-
netic basis of adaptive evolution.
Conclusion
We show here that histone modifications, i.e., changes in 
the epigenetic information can be a source of phenotypic 
variants in the parasite S. mansoni. These phenotypic 
variants are adaptive since they confer a higher fitness 
to the parasite by increasing its infection success in the 
intermediate mollusk host. It is conceivable that environ-
mental clues trigger epigenetic variation and thus con-
tribute to exploring the adaptive landscape. The genetic 
and molecular bases for the generation of epigenetic vari-
ants have not been investigated in this study.
Methods
Ethics statement
Our laboratory has permission A 66040 from both French 
Ministère de l’agriculture et de la pêche and French 
Ministère de l’Education Nationale de la Recherche et de 
la Technologie for experiments on animals and certificate 
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for animal experimentation (authorization 007083, 
decree 87-848 and 2012201-0008) for the experimenters. 
Housing, breeding and animal care followed the national 
ethical requirements.
Culture of Schistosoma mansoni parents and hybrids 
strains
We used in this part of the study different strains of S. 
mansoni: SmBRE, SmGH2 and SmLE. Each strain was 
maintained in its sympatric mollusk Biomphalaria 
glabrata strain (BgBRE, BgGUA and BgBAR2, respec-
tively) as intermediate host and in hamsters (Mesocri-
cetus auratus) as definitive host as described previously 
[36]. Three generations of hybrids of SmBRE and SmGH2 
were produced as follows. Monomiracidial infections 
were performed within each strain of mollusk BgBRE 
and BgGUA. We obtained clonal populations of cercariae 
after 4 weeks. Sex was determined by PCR as described 
before [37, 38]. Strain hybrids were produced by infec-
tion of hamsters with 300 cercariae: 200 males from a 
clonal cercarial population and 100 females from another 
clonal population for each generation. Different com-
binations of parental cercariae were used for each gen-
eration in order to generate biological replicates. Three 
months later, eggs were collected from hamster livers 
and hatched in spring water. Miracidia were divided into 
three parts: (1) one part was used for life trait studies; (2) 
a second part was used for pedigree; and (3) a third part 
was concentrated by sedimentation on ice for 30 min and 
stored for molecular analysis at −20 °C.
SmBRE sporocysts transfer into BgBRE and BgGUA mollusks
SmBRE miracida freshly hatched from a mouse liver 
were used to perform single miracidium infection of a 
dozen BgBRE, as detailed in [39]. Thirty days later, mol-
lusks were screened for presence of parasites. Two mol-
lusks with a large number of sporocysts were selected as 
donors for sporocyst grafts.
Grafts were performed as described in [40, 41]. This 
technique allows to transplant secondary sporocysts 
from one mollusk to another. Grafted secondary spo-
rocysts revert to primary sporocysts and then underdo 
normal development until cercariae emission. Large 
(10–12 mm) BgBRE and BgGUA mollusks were selected 
as receivers and anesthetized by incubating 4 h in spring 
water mixed with sodium pentobarbital at a final concen-
tration of 1.2 mg/mL. Shells of mollusk donors were care-
fully removed with tweezers, and their digestive gland 
(where secondary sporocysts are located) was recov-
ered. Explants of 1 mm3 containing 1–3 sporocysts were 
prepared and grafted (within an hour) in the cephalo-
pedal sinus of receiver snails with a custom-made glass 
microneedle attached to a 1-mL syringe. A small inci-
sion of the tegument above the genital pore was made to 
reach the cephalopedal sinus. Grafted snails were main-
tained in normal growing conditions. Sporocysts from 
the first mollusk donor were grafted in 16 BgGUA and 14 
BgBRE, and sporocysts from the second mollusk donor 
were transplanted in 17 BgGUA and 15 BgBRE.
Sixty days after transplantation, mollusks were 
screened for presence of parasites by searching for sec-
ondary sporocysts under a stereomicroscope and by 
looking for cercariae emission. Grafts were considered 
successful if both conditions were met. Fisher’s exact test 
for count data was used to compare between sympatric 
and allopatric sporocyst transfer success. The experiment 
was done in duplicates.
Sex identification of cercariae
Four weeks after the monomiracidial infestation of mol-
lusk for each generation SmBRE F0, SmGH2 F0, F1 and 
F2, four clonal cercariae were selected from each mollusk 
in order to identify the sex by PCR [37, 38]. After DNA 
extraction from single cercariae, PCR was performed 
using two pairs of primers, two control primers that 
amplify Rhodopsin [Smp_scaff001984 (49840–50016)] 
on male and female, and two female-specific primers that 
amplify SmWSPP2 [Smp_scaff002739 (2682–3046)] only 
on female (Additional file  4). If all four reactions deliv-
ered the same result, we considered sex as identified. We 
then chose male and female clones to infect hamsters and 
produce the next generation.
Pharmacological induction by Trichostatin A treatment
After dissection of 4 infested hamsters (2 by strain), liv-
ers were collected and divided into two equal parts to 
compensate for a potential host bias. Two half livers 
for each strain SmLE and SmGH2 were incubated in 
20 mL 150 mM NaCl and 0.1–0.3 % ethanol as control. 
For the treatment, two half livers for each strain SmLE 
and SmGH2 were incubated in 20  mL NaCl, and 20  µl 
of 20  mM Trichostatin A (TSA) (InvivoGen met-tsa-5) 
dissolved in ethanol was added two times at an inter-
val of 12 h. Livers were incubated overnight at 4 °C. The 
next day, directly after grinding livers, another 20  µl of 
20 mM TSA was added to the eggs from treated livers for 
SmLE and SmGH2. This strategy was chosen since TSA 
is known to be instable [42]. The final concentration of 
TSA was 20  µM in 150  mM NaCl and 0.1–0.3  % etha-
nol (solvent), and total treatment time was 16  h. Mira-
cidia (non-treated SmGH2, treated SmGH2, non-treated 
SmLE and treated SmLE) were divided into two parts (1) 
for prevalence and intensity analysis and (2) for Western 
blot analysis.
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Compatibility of S. mansoni with mollusk hosts
Single mollusks (n =  30–50) were exposed to 20 mira-
cidia each in 5 ml of spring water overnight at 24–25 °C. 
Prevalence was measured 15  days post-exposure, by 
determining the rate of infected mollusks over the entire 
mollusks that were exposed to parasites. The intensities 
were evaluated by counting the number of mother spo-
rocysts that developed within infected mollusk as pre-
viously described [43]. For selection experiments, the 
SmBRE strain was used for 6 generations on the BgGUA 
and BgVEN snail strains, respectively. Prevalences were 
determined at each passage. We named SmBREg and 
SmBREv these schistosome strains maintained on het-
eropatric snail hosts. At each generation, infectivity of 
SmBREg and SmBREv was tested vis-à-vis the original 
sympatric BgBRE snail strain.
Western blot
One thousand miracidia were individually collected, 
counted and incubated in 30  µl Lämmli buffer, 5  min 
at 99  °C. Fifteen µl were separated by electrophoresis 
through a 10  % SDS-PAGE gel and blotted on a nitro-
cellulose membrane (Trans-Blot turbo, Bio-Rad). The 
membrane was blocked with 5  % skimmed dry milk in 
TBST (TBS buffer containing 0.05  % Tween 20) for 1  h 
at room temperature and then incubated with the pri-
mary antibody “anti-SmPoMuc” [19] diluted 1/500 in 
TBST for 90  min at room temperature. The membrane 
was then incubated with secondary antibody (peroxidase 
conjugated, purified anti-rabbit IgG) diluted 1/5000 in 
TBST for 1 h and washed three times with TBST. Finally, 
proteins were detected with a ChemiDoc MP Imaging 
system (Bio-Rad) using ECL reagents. Images were con-
verted into 256 grayscales, and analysis was done with 
ImageJ [44].
RNA extraction, reverse transcription and quantitative PCR
Messenger RNAs were isolated from 500 to 5000 mira-
cidia from each strain using the Dynabeads® mRNA 
DIRECT Micro Kit (Invitrogen). The samples were put 
directly into 100 µl lysis buffer at −80 °C and processed 
according to the manufacturer’s instructions. After wash-
ing, the samples were resuspended directly in 20 µl of 
DNase treatment mix (Ambion RNA by Life Technolo-
gies DNA-free). cDNA were synthesized from 13  µl of 
the total mRNA preparation, in a final volume of 20  µl 
using the RevertAid Premium First Strand cDNA Syn-
thesis Kit by Thermo Scientific. Quantitative PCR analy-
ses were carried out using 2.5  µl of cDNA diluted 1/10 
in a final volume of 10  µl (1.5  µl H2O, 0.5  µM of each 
primer, 5  µl of master mix), using a LightCycler® 480 
Real-Time Instrument, and 2.5 µl of mRNA diluted 1/20 
as negative control for the specific exon junctions ampli-
fications. Alpha-tubulin (α-tub) was used as reference. 
Primer sequences are listed in Additional file 4. The fol-
lowing protocol was used: denaturation, 95  °C 10  min, 
amplification and quantification (45 cycles), 95  °C for 
10 s, 60 °C for 5 s, 72 °C for 20 s; melting curve, 65–97 °C 
with a heating rate of 0.11 C/s and continuous fluores-
cence measurement, and cooling step to 40 °C. For each 
reaction, the crossing point cycle threshold (Ct) was 
determined using the “second derivate” method of the 
LightCycler® 480 Software release 1.5.0. Reactions were 
carried out in duplicate then the mean Ct was calculated. 
The amplification of a unique band of each locus was ver-
ified by size separation on a LabChip GX capillary elec-
trophoretic system.
Chromatin immunoprecipitation (ChIP) followed by qPCR
Native chromatin immunoprecipitation was performed 
as described before [45]. The following antibodies against 
histone isoforms were used to precipitate chromatin in 
miracidia: Abcam anti-H3K9me3 (ab8898, Lot 733951) 
and Millipore anti-H3K9ac (07-352, Lot DAM1576933). 
Immunoprecipitated DNA was extracted by phenol/
chloroform protocol and analyzed by quantitative PCR 
using specific primers for SmPoMuc 3.1(r1–r2) pro-
moter (primer sequences in Additional file 4) and for the 
Smp_171100. The amount of target DNA recovered in the 
immunoprecipitated fraction was quantified by calculating 
the percent of input recovery (% IR) normalized with the 
percent input recovery obtained with α-tubulin gene. The 
percent input recovery of the bound immunoprecipitated 
fraction for each amplicon was calculated by the following 
formula: % input recovery = 100 × E(Ct (input) − Ct (IPBound)). 
The percent background was calculated by the following 
formula: % background  =  100  ×  E(Ct (input)  −  Ct (C-Bound)), 
where E is the primer efficiency designed to amplify the 
amplicon, Ct (IPBound) is the Ct of the bound fraction 
obtained in the immunoprecipitated sample, Ct (C-Bound) 
is the Ct of the bound fraction obtained in the negative 
control (fraction without antibody) and Ct (input) is the Ct 
of the unbound fraction obtained in the negative control. 
It represents the quantity of chromatin that was used for 
the study minus the fraction that bound non-specifically 
to the protein A Sepharose beads. Finally, the ratios of the 
H3K9me3 to H3K3Ac for each gene was calculated using 
formulas (2ct (α-tub)/2ct (SmPoMuc 3.1(r1r2)) and 2ct (α-tub)/2ct 
(Smp_171100)).
DNA extraction, PCR amplification and Sanger sequencing
Genomic DNA for SmBRE F0, SmGH2 F0, F1, F2 and F3 
miracidial population, was prepared by the incubation 
during 3  h at 55  °C with 500  µl of lysis buffer (20  mM 
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Tris/Cl Ph 8; 1  Mm EDTA; 100  mM NaCl; 0.5  % SDS) 
and 0.15 mg of proteinase K. The samples were extracted 
twice with equal volumes of phenol/chloroform, followed 
by two extractions of equal volumes of chloroform. DNA 
was precipitated with equal volumes of isopropoanol/
NaOAc (3 M, pH 5.2) at room temperature. After centrif-
ugation and washing with 1 ml of 70 % ethanol, the pellet 
was dissolved in 50 µl of 1 mM Tris/Cl pH 8.
In order to determine whether the chromatin structure 
follows the Mendelian transmission or not (co-segregate 
with the allele or not), we focus specifically on sequences 
where we determined the chromatin structure by ChIP-
qPCR for SmBRE F0, GH2 F0, F1, F2 and F3 miracidial 
population. We identified 3 SNPs between SmBRE F0 
and GH2 F0 for SmPoMuc 3.1(r1r2) promoter sequence 
and 6 SNPs for Smp_171100 sequence using Sequencer 
software. Primers including SNPs for the two loci were 
designed, and the regions were amplified by qPCR. For 
the SmPoMuc 3.1(r1r2) promoter, qPCR was applied on a 
9 kb PCR product containing the 2-kb region upstream of 
the transcription start site (TSS) [21], and for Smp_171100 
sequence, qPCR was applied directly on genomic DNA 
for SmBRE F0, SmGH2 F0, F1, F2 and F3 miracidial popu-
lation. qPCR products were sequenced using Eurogentec 
facilities (http://www.eurogentec.com/life-science.html). 
We checked and aligned nucleotide sequences manually 
using Sequencer and BioEdit softwares.
Statistical analysis
Fisher’s exact test was used to compare prevalences and 
T test to compare intensities. For the statistical differ-
ences in the amount of transcripts, we used ANOVA with 
Dunnett’s post hoc test using the parental strain SmBRE 
as control group.
Additional files
Additional file 1. Infection success after sporocyst transfer. SmBRE 
sporocysts succeed to infect the two strains of mollusks BgBRE and BgGUA 
and the vertebrate host.
Additional file 2. TSA treatment results. This table contains results of all 
TSA experiments.
Additional file 3. Schematic representation of compatibility polymor‑
phism and influence of changes in the epigenotype. On the left a high 
compatibility situation: the hypothetical inbred S. mansoni strain “white” 
can infect successfully the B. glabrata strain “MOSTLY WHITE” because most 
snails are compatible “white.” However, SmWHITE cannot infect B. glabrata 
“dark” snails. On the right, the incompatible situation in which the same 
SmWHITE strain is exposed to a BgDARK strain. None of the BgDARK can 
be infected by SmWHITE. If SmWHITE is treated with TSA, new phenotypic 
variants develop. Some of them (e.g., SmBLACK) are also incompatible 
with the snail hosts; others can infect (e.g., SmGRAY). By increasing the 
phenotypic variants in the inbred strain through epimutations, the reac‑
tion norm of the strain becomes larger and previously incompatible hosts 
can be infected.
Additional file 4. Primers used in this study.
Abbreviations
SmPoMuc: Schistosoma mansoni polymorphic mucins; SmBRE: Schistosoma 
mansoni strain Brazil BRE; SmLE: Schistosoma mansoni strain Brazil LE; SmGH2: 
Schistosoma mansoni strain Guadeloupe GH2; BgBRE: Biomphalaria glabrata 
strain Brazil BRE; BgGUA: Biomphalaria glabrata strain Guadeloupe GUA; BgBAR: 
Biomphalaria glabrata strain Brazil BAR; ChIP: chromatin Immunoprecipitation; 
H3K9ac: histone H3 acetylated on lysine 9; H3K9me3: histone H3 tri‑methyl‑
ated on lysine 9; TSA: trichostatin A.
Authors’ contributions
SF, AT, AR, BA, DD, JBu and CG designed and performed the experiments. SF, 
CC, GM and CG wrote the manuscript. AR and DR performed sporocyst trans‑
fer. NA raised the animals. JBo performed the statistical analysis. All authors 
read and approved the final manuscript.
Author details
1 IHPE, Université de Perpignan Via Domitia (UPVD), 52 Avenue Paul Alduy, 
66860 Perpignan Cedex, France. 2 CNRS, UMR 5244, Interactions Hôtes‑
Pathogènes‑Environnements (IHPE), 66860 Perpignan, France. 3 CNRS, 
UPR1142, Institut de Génétique Humain (IGH), 34396 Montpellier, France. 
4 Technical University of Munich (TUM), Liesel‑Beckmann‑Str. 2, 85354 Freising, 
Germany. 5 UMR BDR, INRA, ENVA, Université Paris Saclay, 78350 Jouy en Josas, 
France. 
Acknowledgements
We would like to thank Benjamin Gourbal, Claudine Junien and Richard Galinier 
for fruitful discussions. We thank also Anne Rognon and late Bernard Dejean for 
providing valuable technical support. Special thanks go to G. Olivieira (Instituto 
Nacional de Ciência e Tecnologia em Doenças Tropicais, Fundacao Oswaldo 
Cruz, Brazil) for the generous gift BgBAR / SmLE strains (SIBIO license 42195). 
This work is dedicated to our friend and colleague Jérôme Buard who passed 
away during the writing of this manuscript.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was supported by the French National Agency for Research (ANR‑
2010‑BLAN‑1720‑01; EPIGEVOL).
Received: 22 March 2016   Accepted: 24 June 2016
References
 1. Darwin C. The variation of animals and plants under domestication. 
London: John Murray publisher;1868.
 2. Klironomos FD, Berg J, Collins S. How epigenetic mutations can affect 
genetic evolution: model and mechanism. BioEssays. 2013;35(6):571–8.
 3. Maynard Smith J. Models of a dual inheritance system. J Theor Biol. 
1990;143:41–53.
 4. Pal C, Miklos I. Epigenetic inheritance, genetic assimilation and specia‑
tion. J Theor Biol. 1999;200:19–37.
 5. Waddington CH. The epigenotype. Int J Epidemiol. 1942;41(1):10–3.
 6. Tal O, Kisdi E, Jablonka E. Epigenetic contribution to covariance between 
relatives. Genetics. 2010;184(4):1037–50.
 7. Frésard L, Morisson M, Brun JM, Collin A, Pain B, Minvielle F, Pitel F. Epige‑
netics and phenotypic variability: some interesting insights from birds. 
Genet Sel Evol. 2013;45:16.
 8. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. Epigenetic inheritance 
at the agouti locus in the mouse. Nat Genet. 1999;23(3):314–8.
 9. Cortijo S, Wardenaar R, Colomé‑Tatché M, Gilly A, Etcheverry M, Labadie 
K, Caillieux E, Hospital F, Aury JM, Wincker P. Mapping the epigenetic basis 
of complex traits. Science. 2014;343(6175):1145–8.
 10. Rassoulzadegan M, Grandjean V, Gounon P, Vincent S, Gillot I, Cuzin F. 
RNA‑mediated non‑Mendelian inheritance of an epigenetic change in 
the mouse. Nature. 2006;441(7092):469–74.
 11. Manning K, Tör M, Poole M, Hong Y, Thompson AJ, King GJ, Giovannoni 
JJ, Seymour GB. A naturally occurring epigenetic mutation in a gene 
Page 13 of 13Fneich et al. Epigenetics & Chromatin  (2016) 9:27 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
encoding an SBP‑box transcription factor inhibits tomato fruit ripening. 
Nat Genet. 2006;38(8):948–52.
 12. Hotez PJ, Kamath A. Neglected tropical diseases in sub‑Saharan Africa: 
review of their prevalence, distribution, and disease burden. PLoS Negl 
Trop Dis. 2009;3(8):e412.
 13. Morgan JA, Dejong RJ, Adeoye GO, et al. Origin and diversification of the 
human parasite Schistosoma mansoni. Mol Ecol. 2005;14:3889–902.
 14. Mitta G, Adema CM, Gourbal B, Loker ES, Theron A. Compatibility 
polymorphism in snail/schistosome interactions: from field to theory to 
molecular mechanisms. Dev Comp Immunol. 2012;37(1):1–8.
 15. Theron A, Rognon A, Gourbal B, Mitta G. Multi‑parasite host susceptibility 
and multi‑host parasite infectivity: A new approach of the Biomphalaria 
glabrata/Schistosoma mansoni compatibility polymorphism. Infect Genet 
Evol. 2014;26:80–8.
 16. Roger E, Mitta G, Moné Y, Bouchut A, Rognon A, Grunau C, Boissier J, 
Théron A, Gourbal B. Molecular determinants of compatibility polymor‑
phism in the Biomphalaria glabrata/Schistosoma mansoni model: New 
candidates identified by a global comparative proteomics approach. Mol 
Biochem Parasitol. 2008;157(2):205–16.
 17. Roger E, Grunau C, Pierce RJ, et al. Controlled chaos of polymorphic 
mucins in a metazoan parasite (Schistosoma mansoni) interacting 
with its invertebrate host (Biomphalaria glabrata). PLoS Negl Trop Dis. 
2008;2:e330.
 18. Roger E, Gourbal B, Grunau C, Pierce RJ, Galinier R, Mitta G. Expression 
analysis of highly polymorphic mucin proteins (SmPoMuc) from the para‑
site Schistosoma mansoni. Mol Biochem Parasitol. 2008;157(2):217–27.
 19. Moné Y, Gourbal B, Duval D, Du Pasquier L, Kieffer‑Jaquinod S, Mitta G. 
A large repertoire of parasite epitopes matched by a large repertoire of 
host immune receptors in an invertebrate host/parasite model. PLoS 
Negl Trop Dis. 2010;4:e813.
 20. DeMarco R, Mathieson W, Manuel SJ, Dillon GP, Curwen RS, Ashton PD, 
Ivens AC, Berriman M, Verjovski‑Almeida S, Wilson RA. Protein variation in 
blood‑dwelling schistosome worms generated by differential splicing of 
micro‑exon gene transcripts. Genome Res. 2010;20(8):1112–21.
 21. Perrin C, Lepesant JM, Roger E, et al. Schistosoma mansoni mucin gene 
(SmPoMuc) expression: epigenetic control to shape adaptation to a new 
host. PLoS Pathog. 2013;9:e1003571.
 22. Cosseau C, Azzi A, Rognon A, Boissier B, Gourbière S, Roger E, Mitta G, 
Grunau C. Epigenetic and phenotypic variability in populations of Schis-
tosoma mansoni—a possible kick‑off for adaptive host/parasite evolution. 
Oikos. 2010;119(4):669–78.
 23. Clément JA, Toulza E, Gautier M, Parrinello H, Roquis D, Boissier J, Rognon 
A, Moné H, Mouahid G, Buard J, et al. Private selective sweeps identified 
from next‑generation pool‑sequencing reveal convergent pathways 
under selection in two inbred Schistosoma mansoni strains. PLoS Negl 
Trop Dis. 2013. doi:10.1371/journal.pntd.0002591.
 24. Lepesant JM, Grunau C, Cosseau C. Towards an understanding of the 
epigenetics of schistosomes: a comparative epigenomic study. Mem Inst 
Oswaldo Cruz. 2011;106:823–30.
 25. Lopez‑Atalaya JP, Ito S, Valor LM, Benito E, Barco A. Genomic targets, and 
histone acetylation and gene expression profiling of neural HDAC inhibi‑
tion. Nucleic Acids Res. 2013;41:8072–84.
 26. Halsall J, Gupta V, O’Neill LP, Turner BM, Nightingale KP. Genes are often 
sheltered from the global histone hyperacetylation induced by HDAC 
inhibitors. PLoS One. 2012;7(3):e33453.
 27. Andrews KT, Gupta AP, Tran TN, Fairlie DP, Gobert GN, Bozdech Z. 
Comparative gene expression profiling of P. falciparum malaria parasites 
exposed to three different histone deacetylase inhibitors. PLoS One. 
2012;7(2):e31847.
 28. Ehrenkaufer GM, Eichinger DJ, Singh U. Trichostatin A effects on gene 
expression in the protozoan parasite Entamoeba histolytica. BMC Genom. 
2007;8(1):216.
 29. Hochholdinger F, Hoecker N. Towards the molecular basis of heterosis. 
Trends Plant Sci. 2007;12:427–32.
 30. Baranwal VK, Mikkilineni V, Zehr UB, Tyagi AK, Kapoor S. Heterosis: 
emerging ideas about hybrid vigour. J Exp Bot (Soc Experiment Biol). 
2012;63:6309–14.
 31. Kiani J, Grandjean V, Liebers R, Tuorto F, Ghanbarian H, Lyko F, Cuzin F, Ras‑
soulzadegan M. RNA–mediated epigenetic heredity requires the cytosine 
methyltransferase Dnmt2. PLoS Genet. 2013;9(5):e1003498.
 32. Geyer KK, Chalmers IW, Mackintosh N, Hirst JE, Geoghegan R, Badets M, 
Brophy PM, Brehm K, Hoffmann KF. Cytosine methylation is a conserved 
epigenetic feature found throughout the phylum Platyhelminthes. BMC 
Genom. 2013;14(1):462.
 33. Sire C, Durand P, Pointier JP, Théron A. Genetic diversity and recruitment 
pattern of Schistosoma mansoni in a Biomphalaria glabrata snail popula‑
tion: a field study using random‑amplified polymorphic DNA markers. J 
Parasitol. 1999;85:436–41.
 34. Anderson R, Mercer J, Wilson R, Carter N. Transmission of Schistosoma 
mansoni from man to snail: experimental studies of miracidial survival 
and infectivity in relation to larval age, water temperature, host size and 
host age. Parasitology. 1982;85(02):339–60.
 35. De Mendonça RL, Escrivá H, Bouton D, Laudet V, Pierce RJ. Hormones 
and nuclear receptors in schistosome development. Parasitol Today. 
2000;16(6):233–40.
 36. Théron A, Pages JR, Rognon A. Schistosoma mansoni: distribution patterns 
of miracidia among biomphalaria glabrata snail as related to host suscep‑
tibility and sporocyst regulatory processes. Exp Parasitol. 1997;1–9.
 37. Portela J, Grunau C, Cosseau C, Beltran S, Dantec C, Parrinello H, Boissier 
J. Whole‑genome in‑silico subtractive hybridization (WISH) ‑ using 
massive sequencing for the identification of unique and repetitive sex‑
specific sequences: the example of Schistosoma mansoni. BMC Genom. 
2010;11:387.
 38. Lepesant JMJ, Boissier J, Climent D, Cosseau C, Grunau C. Female biased 
sex‑ratio in Schistosoma mansoni after exposure to an allopatric interme‑
diate host strain of Biomphalaria glabrata. Exp Parasitol. 2013;135:350–6.
 39. Boissier J, Mone H. Experimental observations on the sex ratio of adult 
Schistosoma mansoni, with comments on the natural male bias. Parasitol‑
ogy. 2000;121(04):379–83.
 40. Jourdane J, Theron A. Schistosoma mansoni: cloning by microsurgical 
transplantation of sporocysts. Exp Parasitol. 1980;50(3):349–57.
 41. Jourdane J. Maintenance of a male and a female clone of Schistosoma 
mansoni by microsurgical transplantation of sporocysts. Reliability 
of the method. Annales de parasitologie humaine et comparee. 
1983;59(4):361–7.
 42. Grunau C, Buard J, Brun ME, De Sario A. Mapping of the juxtacentromeric 
heterochromatin‑euchromatin frontier of human chromosome 21. 
Genome Res. 2006;16(10):1198–207.
 43. Théron A, Gerard C. Development of accessory sexual organs in 
Biomphalaria glabrata (Planorbidae) in relation to timing of infection by 
Schistosoma mansoni: consequences for energy utilization patterns by 
the parasite. J Molluscan Stud (Malacol Soc Lond). 1994;60:25–31.
 44. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with imagej. 
Biophotonics Int. 2004;11:36–42.
 45. Cosseau C, Azzi A, Smith K, Freitag M, Mitta G, Grunau C. Native 
chromatin immunoprecipitation (N‑ChIP) and ChIP‑Seq of Schistosoma 
mansoni: Critical experimental parameters. Mol Biochem Parasitol. 
2009;166(1):70–6.
